Ledger.Open graph →

SEC Form D · Amendment · filed August 1, 2011

Pulse Therapeutics, Inc

Offering

$2.0M

Sold

$1.6M

Exemption

—

Industry

Biotechnology

Location

ST. LOUIS, MO

Type

—

People & firms on this filing (14)

Amy L. Boyet · St. Louis, MOExec Rogers Ritter · St. Louis, MOExec Bevil J. Hogg · St. Louis, MODirector Francis M. Creighton · St. Louis, MOExec · Director Thomas J. Hillman · St. Louis, MODirector Daniel J. Broderick · St. Louis, MODirector Stephen A. Wexler · St. Louis, MODirector Martin Hall · Cupertino, CAExec · Director Ann Winblad · Cupertino, CAExec David Liddle · Cupertino, CADirector Gail Ennis · Cupertino, CAExec Debby Meredith · Cupertino, CADirector Daniel Moskowitz · Cupertino, CADirector Corey S. Johnson · Nashville, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗